A 2025 review synthesizes progress in deploying stem cells and engineered immune cells to counter age-related decline, reflecting the field’s push toward targeted, mechanism-informed interventions that aim to improve healthspan alongside lifespan.
Emerging strategies emphasize precision control of cell fate, immune modulation, and rejuvenation of niche environments to sustain organ function in aging populations.